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Manfred KayserIn the current world of genetic publishing and multi-
author papers, where sometimes it is possible that several
hundreds of co-authors are listed on a single article (and
yes, I am thinking of genome-wide association studies
here), I am always intrigued by single author papers.
Hence, a not too recent paper by Szabolcs Kéri from
Semmelweis University in Budapest drew my attention,
also because of the interesting title ‘Genes for psychosis
and creativity’ [1]. This reminded me of the German say-
ing, ‘Genie und Wahnsinn liegen oft dicht beieinander,’
which translates as: genius and madness are often at close
quarters, and is similar, but not quite the same as the
English phrase, ‘There is a fine line between genius and
madness.’ Does this study provide one of the not so
frequent cases where a layman observation that led to
commonly used phrases, even in different languages,
eventually receives scientific proof?
Previous studies had suggested that the neuregulin I
gene, which is involved in neuronal development, synap-
tic plasticity, glutamateric neurotransmission and glial
function, serves as a candidate gene for psychosis [2]. In
particular, the T/T genotype of the functional promoter
polymorphism SNP8NRG243177 or rs6994992, which
leads to increased neuregulin I gene expression, is asso-
ciated with an increased risk of psychosis and other psy-
chological and neurological phenotypes [3,4]. Kéri
investigated whether this particular DNA variant also
has an advantageous effect. He studied 200 healthy vol-
unteers with high intellectual performance as measured via
a battery of tests and questionnaires, who were genotyped
at the neuregulin 1 promoter DNA variant rs6994992.
Grouping these 200 high intellectual achievers according
to rs6994992 genotypes revealed that the T/T carriers had
statistically significantly higher creativity measures com-
pared with the C/C and the C/T carriers, with the C/T het-
erozygotes usually performing at an intermediate level
relative to the T/T and the C/C homozygotes. No signifi-
cant differences between individuals belonging to these
three genotype groups were observed for other parametersCorrespondence: m.kayser@erasmusmc.nl
Department of Forensic Molecular Biology, Erasmus MC University Medical
Centre Rotterdam, PO Box 2040, 3000, Rotterdam, CA, The Netherlands
© 2013 Kayser; licensee BioMed Central Ltd. T
Commons Attribution License (http://creativec
reproduction in any medium, provided the ortested, such as age, gender, education, socioeconomic sta-
tus, intelligence quotient (IQ), employment, marriage, and
so on. Two additional DNA variants from the neuregulin I
gene that are not implicated in psychosis and do not affect
gene expression were also tested and did not indicate simi-
lar associations. Based on these data, Kéri argues that the
neuregulin I gene, previously implicated in psychosis and
altered brain structure and function, has a significant im-
pact on human creativity.
Is this evidence enough to support the conclusion that
genius and madness are indeed related to each other be-
cause they are determined by the same gene? The author
himself already admits some caveats in his study, such
as that the findings were obtained from a selected group
of people with high intellectual performance. It may be
(as was not tested) that the observed effect is not found
in an intellectually less-prominent sample. He also
points out that in the general population rs6994992 is
not associated with schizotypical traits as reported previ-
ously [5]. Furthermore, genetic evidence on the involve-
ment of neuregulin 1 in psychotic conditions appears
not without doubt. For instance, while some candidate
gene studies reported the association of neuregulin-1
DNA variants with schizophrenia (for example [6]) and a
genome-wide linkage analysis highlighted a candidate re-
gion for schizophrenia that includes the neuregulin-1 gene
[7], several genome-wide association studies highlighted
genes other than neuregulin-1 to be involved in schizo-
phrenia (for example [8,9]).
If Kéri’s findings indeed reflect a general trend and if,
indeed, the neuregulin 1 gene determines psychotic con-
ditions, the question on how the rs6994992T/T genotype
leads to higher creativity will be of interest. The author
suggests that reduced cognitive inhibition, known to be
related to schizotypical features and associated with in-
creased creativity in people with high intelligence, may
be the key here, but data on the direct role of rs6994992
in reduced cognitive inhibition is missing thus far.
Clearly, much further work needs to be done before
scientific data allow us to conclude whether madness
and genius indeed share biological determination and,
thus, can be considered to be at close quarters, or not.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.investigativegenetics.com/content/4/1/14Until this is achieved, we may keep using the saying
‘Genie und Wahnsinn liegen oft dicht beieinander, ’ but
need to be aware that scientific evidence clearly
supporting it is still lacking.
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